Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes

Anti-tumor necrosis factor-α (TNFα) therapy has improved the prognosis of many chronic inflammatory diseases. It appears to be well-tolerated by liver-transplant patients. However, their use and their safety in kidney-transplant patients have yet to be determined. In this retrospective study, we ide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Garrouste, Cyril, Anglicheau, Dany, Kamar, Nassim, Bachelier, Claire, Rivalan, Joseph, Pereira, Bruno, Caillard, Sophie, Aniort, Julien, Gatault, Philippe, Soubrier, Martin, Sayegh, Johnny, Colosio, Charlotte, Buisson, Anthony, Thervet, Eric, Bouvier, Nicolas, Heng, Anne Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
5200
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072954/
https://ncbi.nlm.nih.gov/pubmed/27741127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados